Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The gut-brain axis in Alzheimer's disease: early detection, microbial metabolites, mechanisms, and therapeutic opportunities.

Frontiers in molecular biosciences·2026
Same author

Alzheimer's disease neuroimaging signature aids identification of cognitive impairment in older adults with early-onset epilepsy.

medRxiv : the preprint server for health sciences·2026
Same author

PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer's disease model.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

AT(N) Framework in Older Adults with Epilepsy: Plasma Biomarkers and Associations with Demographic, Clinical, and Cognitive Features.

medRxiv : the preprint server for health sciences·2026
Same author

Pre-analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Early peripheral immune signaling precedes tau elevation and blood-brain barrier disruption in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Aaron Burberry1, Mark J Lowe2, Wanyong Shin2

  • 1Case Western Reserve Univeristy, Cleveland, OH, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

在阿尔茨海默病 (AD) 外周血液中,性别特异性免疫细胞特征显示为早期生物标志物具有前途. 这些免疫变化与血脑屏障的透性和认知功能相关,提供了新的诊断和治疗途径.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经免疫学 神经免疫学
  • 生物标志物发现发现
  • 阿尔茨海默氏症疾病研究研究

背景情况:

  • 免疫系统的改变与阿尔茨海默病 (AD) 的进展和结果有关.
  • 目前针对阿尔茨海默病的基于血液的生物标志物受到高可变性和与中枢神经系统变化的间接联系的限制.

研究的目的:

  • 用外周血液和脑脊液 (CSF) 来识别阿尔茨海默病 (AD) 中的性别特异性免疫细胞特征.
  • 评估这些免疫特征作为阿尔茨海默氏症早期诊断生物标志物的潜力,以及它们与疾病严重程度和血脑屏障 (BBB) 完整性的相关性.

主要方法:

  • 一项前性队列研究,涉及55名参与者,包括健康对照组,轻度认知障碍 (MCI),AD痴呆和前叶退化 (FTD) 组.
  • 量细胞测量被用来分析周围血液和CSF中的免疫细胞表型.
  • 动态对比增强磁共振 (DCE-MRI) 成像评估了区域BBB透性.

主要成果:

  • 在阿尔茨海默氏症外周血液中确定了一种特定于性别的免疫细胞特征,在女性 (MCI阶段) 和男性 (阿尔茨海默氏症痴呆阶段) 中具有明显的时间模式.
  • 这种免疫细胞特征在识别MCI方面表现出更大的效果大小,相比于已知的AD生物标志物,如粉样蛋白β42/40和酸变体.
  • 免疫特征与海马BBB透性和认知结果有显著的相关性.

结论:

  • 周围血液和CSF中的免疫细胞变化对AD病理学表现出独特的反应能力.
  • 这些发现表明,新的基于免疫的生物标志物有可能用于AD诊断和治疗点.